BTMD vs GANX
Comparison between biote Corp - Class A (BTMD, Company) and Gain Therapeutics Inc (GANX, Company).
Both BTMD and GANX are from the Healthcare sector.
5-Year PerformanceBTMD has outperformed GANX, delivering a return of -24.1% compared to -30.2%
BTMD vs GANX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BTMD vs GANX - Historical Returns
Returns include dividend reinvestment.
BTMD vs GANX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BTMD | GANX |
|---|---|---|
| 2026 | -0.40% | -47.17% |
| 2025 | -56.88% | +38.79% |
| 2024 | +30.66% | -40.41% |
| 2023 | +36.84% | +0.77% |
| 2022 | -62.13% | -42.46% |
| 2021 | -2.49% | -51.52% |
BTMD vs GANX Drawdown Comparison
The maximum drawdown for BTMD was -87.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for GANX was -94.08%, occurring on Aug 13, 2024. This drawdown has not yet recovered.
The current BTMD drawdown is -75.64%. The current GANX drawdown is -89.37%.
| Rank | BTMD | GANX |
|---|---|---|
| #1 | -87.13% May 12, 2021 - Mar 30, 2026 | -94.08% Apr 5, 2021 - Aug 13, 2024 |
| #2 | -1.00% Apr 28, 2021 - May 12, 2021 | -7.95% Mar 22, 2021 - Mar 26, 2021 |
Correlation
Correlation between BTMD and GANX is 0.67 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks